However, The TRPM7 kinase inhibitor TG100-115 exhibited little impact on the proliferation of MDA-MB-231 breast cancer cells, suggesting that the anti-proliferative effect of TRPM7 silencing is not likely tod be related to the structural domain of TRPM7 kinase (Song et al., 2017). The gene discussed is TRPM7; the disease is breast carcinoma.